Retinitis Pigmentosa Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa; Retinitis Pigmentosa Syndrome Intervention: Drug: EA-2353 Sponsor: Endogena Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2022 Category: Research Source Type: clinical trials

A Study in Subjects With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Intervention: Drug: ADX-2191 Sponsor: Aldeyra Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2022 Category: Research Source Type: clinical trials

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of Small Molecule KIO-301 Administered Intravitreally to Patient s With Retinitis Pigmentosa (ABACUS)
Condition: Retinitis Pigmentosa Intervention: Drug: KIO-301 Sponsor: Kiora Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2022 Category: Research Source Type: clinical trials

Structural and Functional Characterization of Rare Ocular Diseases
Condition: Retinitis Pigmentosa, Stargardt's Disease, Best Disease, Pattern Dystrophies, Choroideremia Intervention: Sponsor: Barcelona Macula Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2022 Category: Research Source Type: clinical trials